NHP-PAC Working Group and Member Biography and Summary of Affiliations and Interests Declaration 2011-2012

The following biographies and Summaries of Affiliations and Interests Declarations (SAID) present summarized information related to the expertise and experience offered by each member of the Natural Health Products Program Advisory Committee (NHP-PAC) and a summary of their affiliations and interests.  As outlined in the Terms of Reference of the NHP-PAC, prior to participation as member of the NHP-PAC, all members must receive "enhanced reliability" security clearance, and complete and sign a declaration of affiliations and interests and a confidentiality agreement.

• Committee
• Members of Working Group #1 - Standards of Evidence for Non-Traditional Natural Health Products
• Members of Working Group #2 - Product Testing Requirements Connected to Good Manufacturing Practice Requirements for Natural Health Products
• Members of Working Group #3 - Compliance and Enforcement for Natural Health Products
• Members of Working Group #4 - Weight Loss/Weight Management for Natural Health Products
• Health Products and Food Branch Advisory Body Member Affiliations and Interests Declaration

Committee

Mr. Robin Bell holds a Bachelor of Science (Chemistry) from The Queen's University of Belfast, and is a Certified Dairy Laboratory Director, State of Pennsylvania, in addition to having completed Courses in Food Science, Sanitation and Microbiology at the Universities of Guelph, Michigan and Pennsylvania.

Mr. Bell has over 30 years experience in the drug, food and natural health product (NHP) industries in the fields of technical, regulatory, quality assurance, environmental and policy management. He was actively involved since the beginning in the development of the Natural Health Products Regulations. He has served on the industry/government task force to develop Good Manufacturing Practices for NHPs and completed a three-year term as a member of the Natural Health Products Directorate Management Advisory Committee. He currently represents the Direct Sellers Association (DSA) on Health Canada's Environmental Assessment Working Group.

For 18 years, Mr. Bell held the position of Manager, Technical/Quality services at Amway Canada Corporation, a regulated industry stakeholder and direct seller, and has acted as volunteer chair of the DSA Health & Environment Committee. In that role he has led DSA delegations in annual meetings with various Health Canada Directorates and has organized written responses to regulatory and guideline proposals on a wide variety of subjects. He is also on the forefront in meetings with provincial ministries on the subject of packaging and product stewardship.

Mr. Bell is a past board member of the London Centre for Health, Environment and Safety and of a national consumer products association, and he is a founding member of the Food Forum for industry/government in Southwestern Ontario, where he continues in the role of registrar and treasurer.

SAID - Mr. Bell is a volunteer member of the DSA, an industry trade association that may have an interest in the mandate and work of the NHP-PAC, he may make public statements on issues of relevance to the NHP-PAC mandate.

Dr. Paula Brown has supported the natural health & food product industry for over a decade by conducting applied research at British Columbia Institute of Technology (BCIT) on product quality, safety & efficacy. Supported by grant funding and industry contracts, BCIT has engaged in projects focused on health policy, regulatory affairs, product formulation, botanical authentication, analytical method development & validation, chemometrics and therapeutic monitoring for preclinical and clinical studies.

Dr. Brown was appointed Fellow of the AOAC, in 2009, after serving five years as General Referee, six years on the Dietary Supplement Task Force, participating on seven Expert Review Panels, and directing three collaborative studies. In 2009 she was appointed to the American Botanical Council Advisory Committee, the inaugural Natural Health Products Program Advisory Committee for Health Canada and became Chair of NSF's Joint Committee for Dietary Supplements. She is currently serving her second term as Director of Emerging Sectors for the Investment Agriculture Foundation and is the "Quality Focus" columnist for Nutraceuticals World.

SAID - As part of her role and function with BCIT, Dr. Brown may receive payment or financial support and reimbursement for conference costs from the regulated NHP industry, and she may provide formal advice or opinion on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate.

Mr. Carl Carter has 29 years of regulatory, policy and management expertise in the consumer product and trade association sectors. He is a former member of Health Canada's Natural Health Products Directorate Management Advisory Committee and he Co-Chaired the joint Health Canada/Environment Canada Environmental Assessment Working Group. He has extensive experience in working with broad stakeholder committees, as well as numerous trade association committees, including acting as former Chair and Board member of a national consumer products trade association. He has an Honours B.Sc. (Chemistry & Biology) from Wilfrid Laurier University and is a Certified Association Executive.

Mr. Carter has extensive Canadian and international experience with the regulation and compliance of consumer products, including natural health products, drugs, cosmetics and foods. He has expert knowledge of the Food and Drugs Act and its regulations, the Canadian Environmental Protection Act, Legislative Renewal, Cost Recovery, Packaging Waste and numerous other health and environmental legislation and regulations. He is currently Director of Regulatory Affairs with the Canadian Health Food Association.

SAID - Mr. Carter is a full time employee of the Canadian Health Food Association (CHFA), a national industry trade association which may have an interest in the mandate and work of the NHP-PAC. As part of his role and function with the CHFA, Mr. Carter may provide formal advice or opinion to the regulated industry on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate.

Mr. Lawrence Cheng is a founding director and current Vice President for Regulatory Affairs of the Chamber of Chinese Herbal Medicine of Canada (CCHMC). He also helped to found Sun Ming Hong (Canada) Ltd., in 1983, an importer, distributor and retailer of traditional Chinese medicine as well as one of the most active exporters of Canadian ginseng. His family has a long history in the traditional Chinese medicine industry, dating from the mid-1800s.

SAID - Mr. Cheng holds shares in and receives remuneration from Sun Ming Hong (Canada) Inc. As volunteer member of the CCHMC, an industry trade association that may have an interest in the mandate and work of the NHP-PAC, he may receive reimbursement for conference costs and member dues, may provide formal advice or opinion to the regulated industry on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate. He also participates, as part of his role and function with the CCHMC, in meetings with Health Canada on issues of relevance to the traditional Chinese medicine industry.

Dr. Mary Chou is Senior Scientist and Head of Clinical Research & Regulatory Affairs at Advanced Orthomolecular Research Inc (AOR). She also provides product research and development, technical, marketing, and educational support at AOR. Dr. Chou holds a BSc in Cellular, Molecular, and Microbial Biology, and an MSc and a PhD in Medical Biochemistry and Molecular Biology specializing in cancer research, from the University of Calgary. She has presented her doctoral research at several international conferences, and has published many peer-reviewed studies and articles.

SAID - Dr. Chou is on full-time staff at Advanced Orthomolecular Research Inc, a regulated industry stakeholder and member of the Canadian Health Food Association.

Ms. Christine Clarke is dedicated to health policy development and specifically her interest in ensuring that the regulation of natural health products is pursued in a manner which improves patient care and the health of all Canadians.  She is an active member of the Canadian Skin Patient Alliance, a respected patient organization representing a range of patients suffering from various skin conditions.

The Canadian Skin Patient Alliance is a member organization of the Best Medicines Coalition (BMC) and as such supports the BMC mission and goals of representing patients in the health policy process and ensuring consistent access to treatments for all Canadians.

At the Canadian Skin Patient Alliance, Ms. Clarke has served in a leadership capacity both as a member of the Board of the Directors and as Chair of the Advocacy Committee. In this capacity, she has been actively involved along with other patient representatives in communicating patient positions regarding care to government officials and is currently working with others to create report card on the status of access to care in Canada for skin patients. She is also a regular contributor to a magazine serving these patients.

Professionally, Ms. Clarke's background is varied, having been involved in positions of both an entrepreneurial and managerial capacity for businesses in the educational and technology sectors in her region. She has also been involved in continuing education for adults for various organizations.

SAID - Ms. Clarke is a volunteer member of Best Medicines Coalition, a national patient organization that may have an interest in the mandate and work of the NHP-PAC.

Mr. John Ferris is the President & Chief Executive Officer of Swiss Herbal Remedies Ltd, a manufacturer and distributor of vitamins, minerals and herbal supplements. He holds a Business Administration diploma from Ryerson University and is a strategic and visionary business leader with over 30 years of progressive senior management experience within the consumer packaged goods industry, specifically in the personal care and health and wellness sectors. His dedication to the natural health products industry is unwavering. Mr. Ferris has taken a lead role alongside the Canadian Health Food Association (CHFA) to align industry leaders and government on the appropriate steps to be taken to ensure that consumers can rely on product safety, quality and efficacy, and manufacturers can rely on a vibrant platform to operate from.

SAID - Mr. Ferris is a full-time employee of Swiss Herbal Remedies Ltd., a regulated industry stakeholder.

Ms. Suzanne Gaudette graduated from the Université du Québec à Montréal in 1989 with a Bachelor's degree in Biochemistry and is a member of l'Ordre des Chimistes du Québec. She has been working in the natural health products industry since obtaining her degree. For the past eight years, she has been employed at Heel Canada Inc., a homeopathic products company, in Montreal with head offices in Germany, as the person responsible for Quality Assurance, Quality Control and Regulatory Affairs. She chairs the Technical Committee of the Canadian Homeopathic Pharmaceuticals Association (CHPA). As such, she has participated in working groups and meetings towards advancing legislation and guidance for homeopathic products and has had the opportunity to meet people within the homeopathic products and NHP community in general and also Health Canada representatives to discuss items of interest to CHPA members.

Ms. Gaudette is a school commissioner and has been actively implicated in the Quebec public school system since 1996. She believes that education is the key to the success of our collective future.

SAID - As a full-time employee of Heel Canada Ind., a regulated industry stakeholder and as a volunteer member of the CHPA, a national industry trade association that may have an interest in the mandate and work of the NHP-PAC, Ms. Gaudette may receive reimbursement for conference costs and member dues, may provide formal advice or opinion to the regulated industry on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate.

Dr. Dennis Gorecki is a Professor of Pharmacy at the College of Pharmacy and Nutrition, University of Saskatchewan, and served as Dean from July 1998 to August 2009. He also received a Bachelor of Science in Pharmacy degree and a Ph.D. from this university.

An expert in drug design, pharmaceutical quality control analysis, pharmacopeial standards of drugs, dietary supplements and natural products, Dr. Gorecki has published over 100 research articles and abstracts. For the past 20 years, he has provided oversight and distinguished service to the United States Pharmacopeia (USP), the public standard-setting authority for prescription and over-the-counter medications and dietary supplements manufactured and sold throughout the world. He currently serves on the USP Council of Experts as Chair of the Dietary Supplements Expert Committee.

Dr. Gorecki has taken on a number of Canadian national leadership roles, including president of the Association of Deans of Pharmacy of Canada and the Canadian Council for the Accreditation of Pharmacy Programs, and has been on several pharmacy accreditation site visits, both national and international. He was recently appointed as Chair of the Blueprint for Pharmacy Steering Committee and the Drug Advisory Committee of Saskatchewan, and also served on the National Task Force to Review the Future of Canada's Academic Health Sciences Centres.

Dr. Gorecki has provided expertise, vision and direction for a host of initiatives to advance public health, the education of health professionals and the optimum composition of the Canadian health workforce. These initiatives have included the national Blueprint for Pharmacy Task Force and the Moving Forward Pharmacy Human Resources sector study.

SAID - Dr. Gorecki is a volunteer member of the USP Dietary Supplements Expert Committee, an organization which may have an interest in the mandate and work of the NHP-PAC.

Mr. Adam Kingsley is an Association Executive working for the trade association Consumer Health Products Canada (CHP Canada) which represents the consumer health products industry. After completing his B.Sc. Biology (Honours) at the University of Western Ontario he began working for the Interbrew and Labatt Breweries North America in a Quality Control laboratory. Mr. Kingsley then was hired as a Sensory Analyst for the Labatt's North American research team.

In 2002, Mr. Kingsley was invited to join CHP Canada (then NDMAC) as the Manager of Scientific and Regulatory Affairs. Since that time he has held the positions of Senior Manager of Scientific and Regulatory Affairs and his current role as Associate Director of Public and Regulatory Affairs. In 2006, Mr. Kingsley successfully completed the Association Management Education program and passed the qualifying exam to receive his professional designation as a Certified Association Executive.

For CHP Canada, Mr. Kingsley oversees such regulatory files as: natural health products, data protection, good manufacturing practices, price controls, appeals process, antimicrobials, personal care products, and provincial drug scheduling. Mr. Kingsley is the Association staff representative on the Natural Health Products Sub-Committee, and the Good Manufacturing Practices, Sunscreens, and Scheduling issue specific task forces as well as the staff representative on the Association's Marketing Committee and handles issues related to marketing, advertising, and the preclearance system.

Mr. Kingsley's current appointments include Alternate Member of the Advisory Committee on Management, Health Products and Food Branch, Health Canada, Active Member, Canadian Coalition of Manufacturing Industries, Canadian Manufacturer and Exporters and Representative of the World Self-medication Industry, Codex Committee on Food Labelling, Joint Commission of the World Health Organization and the Food and Agriculture Organization of the United Nations (FAO).

Mr. Kingsley has previously been involved in many Health Canada, Industry Canada, and Environment Canada initiatives during his time with CHP Canada and has sat on a variety of Health Canada advisory bodies. He has also represented the World Self-medication Industry (WSMI) on the Codex Committee on Food Labelling since 2002.

SAID - Mr. Kingsley is a full-time employee of Consumer Health Products Canada (CHP Canada), a national industry trade association that may have an interest in the mandate and work of the NHP-PAC, and a volunteer member of the Advisory Committee on Management, Health Products and Food Branch, Health Canada.

Ms. Manon Lambert has been, since 2005, the Chief Executive Officer and Registrar of the Quebec Order of Pharmacists (QOP). Before joining the QOP, she was the Executive Director of the Association des Pharmaciens en Établissement de Santé, a professional union group representing Quebec pharmacists practicing in public healthcare establishments. In her 25 year career, Ms. Lambert has also held positions at the Réseau des Revues d'Utilisation des Médicaments, a provincial government-run common drug review, from 1991 to 1995. Prior to this she worked as a hospital pharmacist in three hospitals in Montreal from 1986 to 1991.

Ms. Lambert has been a member of several committees and other groups related to the pharmacy profession and the healthcare sector, namely the stakeholders meeting group of the Conseil du médicament, the faculty of pharmacy advisory board at the Université de Montréal, the Provincial Working Group on Pharmacy workforce planning and the Pharmacy Stakeholders Meeting Group.

Ms. Lambert's personal qualities, perfect knowledge of the pharmacy and pharmaceutical environment, leadership as well as professional commitment make her an important asset in QOP's main mission to protect the public, promote quality pharmaceutical care and appropriate use of medication in our society.

SAID - Ms. Lambert has professional affiliations with the Quebec Order of Pharmacists, a provincial professional regulatory body that may have an interest in the mandate and work of the NHP-PAC.

Mr. Gary Leong has over 15 years experience in the natural health products industry. He has managed the scientific and quality function for Boehringer Ingelheim, Natural Factors Nutritional Products Ltd. and Jamieson Laboratories Ltd. As Vice President of Scientific and Technical Affairs at Jamieson Laboratories, he is responsible for Quality Assurance, Quality Control, Regulatory and Consumer Affairs and Research and Development. Mr. Leong holds a B.Sc. in Chemistry and a M.B.A. in Quality Management.

SAID - Mr. Leong is a full-time employee of Jamieson Laboratories Ltd., a regulated industry stakeholder. As part of his function and expertise, Mr. Leong may participate as industry representative in meetings with Health Canada and may act as volunteer speaker on regulatory Good Manufacturing Practice impact updates, including for the Canadian Health Food Association, a national industry trade association which may have an interest in the mandate and work of the NHP-PAC, as well as the Council of Responsible Nutrition, the International Pharmaceutical Academy, Pharmaceutical Sciences Group, Hong Kong-Canada Business Association, the Canadian Functional Food and Nutriceuticals Mission (Taiwan) and the Toronto, Western Ontario, Guelph and McMaster Universities.

Ms. Shawn O'Reilly is the Executive Director and Director of Government Relations for the Canadian Association of Naturopathic Doctors (CAND). Ms. O'Reilly has been involved in the field of natural medicine for over 15 years holding senior positions with two of Canada's professional line nutraceutical companies and a holistic compounding pharmacy prior to joining the CAND in 2002. Previously, Ms. O'Reilly spent 17 years as a senior litigation law clerk and Law Clerk Manager for several top Canadian law firms.

SAID - Ms. O'Reilly is a full-time employee of the CAND, a national not-for-profit professional association that may have an interest in the mandate and work of the NHP-PAC. As part of her role and function with the CAND, Ms. O'Reilly may provide formal advice or opinion to the professional community on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate, and she has participated in meetings with Health Canada.

Mr. Ron Rosenes (B.A.Hon, M.A.) has been an active member of the HIV/AIDS community in Toronto since 1991. Living with HIV since the early days of the epidemic and before the advent of therapies, he began to study complementary and alternative medicine (CAM) informally as a means to support his health. He is a former Russian and French professor who left the workforce in 1991 and began a volunteer life starting as a fundraiser with The AIDS Committee of Toronto (ACT), first as Chair of the AIDS Walk, then from 1995 to 1998 as Board Chair. He was appointed ACT's first Honorary Director in 1999. Mr. Rosenes is also a founding Board Member of the Sherbourne Health Centre, a new primary care clinic in downtown south-east Toronto that is home to a naturopathic and chiropractic clinic that offers free services to people with HIV. He is a long time member of AIDS ACTION NOW! Today, he devotes the bulk of his time to ensuring access to therapies for people with HIV including access to CAM as Vice Chair of the Canadian Treatment Action Council (CTAC), a non-government organization working in policy and advocacy at the national level. He sits on the Ontario Advisory Committee on HIV/AIDS, numerous scientific review committees and is delighted to be a member of the NHP-PAC.

Mr. Rosenes is a frequent contributor of articles on managing HIV disease using a holistic approach to such magazines as Living+ and The Positive Side.

SAID - Mr. Rosenes is a volunteer member of the CTAC, a national patient group that may have an interest in the mandate and work of the NHP-PAC. As part of his role and function with CTAC, Mr. Rosenes has participated in meetings with Health Canada including member of Health Canada advisory committees related to NHPs, and he has published an opinion piece on regulatory issues of relevance to NHPs.

Ms. Hilary Schinkel holds a Master of Science from the University of Guelph and a B.A in Environmental Sciences from York University. She has 15 year experience in regulatory affairs and government relations related to natural health products, cosmetics, foods and drugs, and has authored and co-authored articles on health product regulatory affairs. She holds a Quality Control Certificate from the Pharmaceuticals Sciences Group and is a member of the Canadian Association of Professional Regulatory Affairs. She currently holds the position of Senior Manager with Pfizer Consumer Healthcare and is a member of the Health Canada Working Group on Electronic Submissions.

SAID - Ms. Schinkel is a full-time employee of Pfizer Consumer Healthcare, a regulated industry stakeholder. As part of her role and function with Pfizer Consumer Healthcare, she may provide formal advice or opinion on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate.

Ms. Holly Vengroff is the Director of External Relations for CARP, A New Vision of Aging for Canada, an organization dedicated to the promotion and protection of the rights and quality of life of Canadians 45 and over. With close to 350,000 members, CARP is the most influential advocacy organization for mature Canadians. In her role as Director of External Relations, Ms. Vengroff works with stakeholder groups and government agencies on a variety of concerns for mature Canadians. Her advocacy work has helped CARP advance the rights of millions of Canadians over the age of 45.

Ms. Vengroff began working with CARP in 1985 as a consultant, assisting in the installation of its first computer system and database and creating custom programming. Upon seeing what a vital and important role CARP could play towards the concerns of mature Canadians, Ms. Vengroff decided to take an active role in the organization and has worked at CARP in various capacities through the years, including advocacy and public relations. After a brief move to the United States in 1994 where she raised her family and volunteered in the community, she returned to Toronto in 2000 and resumed her work at CARP.

Ms. Vengroff has and continues to participate in a variety of working groups including the Ontario Industry and Stakeholder Committee, Ontario's Seniors' Secretariat Liaison Committee, Best Medicines Coalition and the Ministry of Small Business and Government Services Consumer Advisory Committee.

SAID - Ms. Vengroff is a volunteer member of Best Medicines Coalition, a national patient group that may have an interest in the mandate and work of the NHP-PAC. As part of her role and function, she is also a volunteer of the Ontario Stakeholder and Industry Committee, affiliated with RxD, a national trade association which may have an interest in the mandate and work of the NHP-PAC.

Dr. Terry Willard is a Clinical Herbalist and holds Ph.D. from the Columbia Pacific University. He is recognized as one of North America's leading Clinical Herbalists and currently serves as the President of the Canadian Association of Herbal Practitioners, as member of the Canadian Council of Herbalist Associations and is a professional member of the American Herbalist Guild. For over thirty five years he has been an active practitioner and teacher and director of the Wild Rose College of Natural Healing. He is a member of the Canadian Health Food Association's Hall of Fame and is the author of twelve books. His latest book is Flower Essence: Emotional Alchemy and Spiritual Evolution.

Dr. Willard lives on an organic herb farm on the Eastern Slopes of the Rocky Mountains, outside Calgary, Alberta, Canada.

SAID - Dr. Willard is a Director and owner of the Wild Rose College of Natural Healing, an organization which may have an interest in the mandate and work of the NHP-PAC, and he is a consultant for the Wild Rose Herb Company and Trophic Canada, regulated industry stakeholders. As volunteer member of the Canadian Council of Herbalists Associations, the Canadian Association of Herbalist Practitioners and the Alberta Association of Herbalist Practitioners, he may provide formal advice or opinion on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate.

Dr. Jawaid Younus holds an M.A. in Public Health, Health Sciences, and an M.A. in Science, Molecular Biology from Boston University, and he was licenced as M.D. in 1985 at the King Edward Medical College. He is a Fellow of the Royal College of Physicians and Surgeons of Canada and was assistant professor at the University of Western Ontario, Faculty of Medicine and Dentistry from 2002 to 2009 and is Associate Professor since that time. He has over 15 years experience as consultant in Oncology/Hematology and as Medical Oncologist/Hematologist, including for the Western Regional Memorial Hospital, the Cancer Care Centre for Southern Interior Kelowna and the Shaukat Kanum Memorial Cancer Hospital. He is currently Medical Oncologist at the London Regional Cancer Program.

Dr. Younus has acted as clinical researcher and has extensive experience in working with stakeholder committees, including as member and expert resource for cancer care support groups and research programs. He is currently a member of the Canadian National Team on Complementary Therapy and Alternative Care under the Socio-behavioral Cancer Research Network, and he is Chair of the Supportive Care Resource Group of the London Regional Cancer Centre.

SAID - As an expert resource and volunteer member of national and provincial associations, Dr. Younus may receive reimbursement from the regulated industry for conference and member costs, may provide formal advice or opinion to the regulated industry on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate.

Members of Working Group #1 Standards of Evidence for Non-Traditional Natural Health Products

Working Group #1 remains active through its NHP-PAC members, and continues to work on the development of the Evidence of Safety and Efficacy for Natural Health Products, Guidelines for Industry.

Committee Members

• Ms. Shawn O'Reilly (Co-chair)
  Executive Director
  Director of Government Relations
  Canadian Association of Naturopathic Doctors
• Mr. Ron Rosenes (Co-chair)
  Vice-Chair
  Canadian Treatment Action Council
• Mr. Carl Carter
  Director, Regulatory Affairs and Policy Development
  Canadian Health Food Association
• Mr. Adam Kingsley
  Associate Director, Public and Regulatory Affairs
  Consumer Health Products Canada

Members of Working Group #2 on Product Testing Requirements Connected to Good Manufacturing Practice Requirements for Natural Health Products

Working Group #2 remains active through its NHP-PAC members, and continues to work on the development of the Standards for Quality Natural Health Products Guidance Document.

Committee Members

• Dr. Paula Brown (Chair)
  Director
  British Columbia Institute of Technology
• Mr. Carl Carter
  Director, Regulatory Affairs and Policy Development
  Canadian Health Food Association
• Mr. Lawrence Cheng
  Vice President, Regulatory Affairs
  Chamber of Chinese Herbal Medicine of Canada
• Ms. Suzanne Gaudette
  Chairperson, Technical Committee
  Canadian Homeopathic Pharmaceuticals Association
• Mr. Gary Leong
  Director, Scientific and Technical Affairs
  Jamieson Laboratories Inc.

Members of Working Group #3 on Compliance and Enforcement Natural Health Products

Committee Members

• Mr. Robin Bell
  Chair, DSA Health & Environment Committee
  Direct Sellers Association
• Dr. Paula Brown
  Director, Applied Research and Integrative Biosciences
  British Columbia Institute of Technology
• Mr. Carl Carter
  Director, Regulatory Affairs and Policy Development
  Canadian Health Food Association
• Mr. Lawrence Cheng
  Vice President, Regulatory Affairs
  Chamber of Chinese Herbal Medicine of Canada
• Dr. Mary Chou
  Senior Research Scientist
  Advanced Orthomolecular Research Inc.
• Mr. John Ferris
  President and Chief Executive Officer
  Swiss Herbal Remedies Ltd.
• Ms. Suzanne Gaudette
  Chairperson, CHPA Technical Committee
  Canadian Homeopathic Pharmaceuticals Association
• Dr. Dennis Gorecki
  Professor, College of Pharmacy & Nutrition
  University of Saskatchewan
• Mr. Adam Kingsley
  Associate Director, Public and Regulatory Affairs
  Consumer Health Products Canada
• Ms. Manon Lambert
  Chief Executive Officer and Registrar, Ordre des pharmaciens du Québec
  National Association of Pharmacy Regulatory Authorities
• Mr. Gary Leong
  Vice-President, Scientific and Technical Affairs
  Jamieson Laboratories Ltd.
• Mr. Ron Rosenes
  Vice-Chair
  Canadian Treatment Action Council
• Ms. Hillary Schinkel
  Senior Manager, Regulatory Affairs
  Pfizer Consumer Healthcare Inc.
• Ms. Holly Vengroff
  Director, External Affairs
  CARP, A New Vision of Aging for Canada
• Dr. Terry Willard
  Clinical Herbalist
  Wild Rose Enterprises Inc.
• Dr. Jawaid Younus
  Head, Medical Oncology Division
  London Health Sciences Centre

Members of Working Group #4 on Weight Loss/Weight Management for Natural Health Products

Committee Members

• Ms. Christine Clarke (Chair)
  Canadian Skin Patient Alliance Advocacy Committee
  Best Medicines Coalition
• Mr. Gary Leong
  Vice-President, Scientific and Technical Affairs
  Jamieson Laboratories Inc.
• Mr. Adam Kingsley
  Associate Director, Public and Regulatory Affairs
  Consumer Health Products Canada
• Dr. Terry Willard
  Clinical Herbalist
  Wild Rose Enterprises Inc.

Not members of the Committee

Dr. Robert Dent
Head, Weight Management Clinic
The Ottawa Hospital, Civic Campus

Mr. John Doherty holds a B.Sc., in Plant Biotechnology from the University of Guelph. Mr. Doherty is Director of Regulatory Affairs for Iovate Health Sciences Research Inc. since 2008. He was Manager of Regulatory and Consumer Affairs with Jamieson Laboratories Ltd. from 1999 to 2008, and was Ginsenoside Research Technician with Phytogen Pharmaceuticals in 1998. Mr. Doherty has developed and managed comprehensive quality tracking and management systems for NHP manufacturing. He has managed the submission of over 900 NHP licence application dossiers with Health Canada's Natural Health Products Directorate and the successful registration of more than 40 different foreign sites under the NHPD Site Licensing requirements. Mr. Doherty has liaised with the regulatory body responsible for Natural Health Products in numerous other countries, including the United States FDA and the Australian TGA.

SAID - Mr. Doherty is a full time employee of Iovate Health Sciences Research Inc., and was an employee at Jamieson Laboratories Inc. (1999-2008), regulated industry stakeholders that may have an interest in the mandate and work of the NHP-PAC.

Mr. Paul-Guy Duhamel
Public Affairs Manager
Dietitians of Canada

Dr. Lowell Greib is a graduate of the University of Waterloo where he earned the degrees: BSc (Biochemistry/Biotechnology) and MSc (Analytical Chemistry). He also holds his Diploma in Naturopathic Medicine (Canadian College of Naturopathic Medicine) as well his Diploma in Sports Nutrition (International Society of Sports Nutrition). His current academic roles include directing the Sports Medicine Program at the Canadian College of Naturopathic Medicine and lecturing in sports nutrition in the graduate studies program at the Canadian Memorial Chiropractic College. Dr. Greib maintains a vibrant sports medicine practice in Huntsville, Ontario (The Sport Lab) focussing on sport injury prevention, therapy and sport nutrition.

Dr. Greib's research interests lie in the clinical application of sports nutrition where he works as a performance nutrition specialist for the professional cycling team 'Team Spidertech powered by C10' and the Ontario Junior Hockey League's 'Huntsville Otters'. He has also fulfilled the role as Medical Director for the GoodLife Fitness Toronto Marathon, Ontario Winter Games, and Ontario Paralympic Winter Championships.

Dr. Greib is active in his profession and in his community. He presently serves on the board of the Canadian Association of Naturopathic Doctors, and as a committee member to the Board of Directors of Drugless Therapy - Naturopathy. Locally he holds the position as Chair of the Huntsville/Lake of Bays Sport Council.

SAID - Dr. Lowell Greib is a Board Member of the Canadian Naturopathic Associations, a national professional body that may have an interest in the mandate and work of the NHP-PAC and that may receive funding from the NHP industry.

Ms. Veronica Kacinik is a registered dietitian working in clinical research at the Canadian Centre for Functional Medicine in Coquitlam, BC. She is trained and certified as a specialist in Childhood, Adolescent and Adult Weight Management through the American Dietetic Association and holds both a Bachelor's and Master's Degree in Nutritional Science from the University of Guelph in Ontario. She completed her dietetic internship in 2004 at St. Michael's Hospital in Toronto and is a member of the College of Dietitians of British Columbia, Dietitians of Canada, and the Canadian Obesity Network.

Throughout her professional career, Veronica has engaged and coached hundreds of individuals on their journey to optimal health through food, nutritional supplementation, physical activity, and behaviour modification. As a dietitian, Veronica has a special interest in the scientific, clinical, and commercial applications of nutrition, functional foods, and nutraceuticals. Her previous experiences include working at the University of Guelph's Human Nutraceutical Research Unit and St. Michael's Hospital, Risk Factor Modification Centre in Toronto, Ontario.

SAID - Ms. Kacinik is an employee of the Canadian Centre for Functional Medicine, a health sector organization that may have an interest in the mandate of the NHP-PAC. She is also a member of the Canadian Obesity Network, a national association, and Dieticians of Canada, a national professional body which may have an interest in the mandate and work of the NHP-PAC.

Dr. David Lau
is Professor of Medicine, Biochemistry and Molecular Biology and Chair of the Diabetes and Endocrine Research Group at the University of Calgary. He is the Editor-in-Chief of the Canadian Journal of Diabetes. Dr. Lau is a practising endocrinologist who specializes in diabetes, obesity and lipid disorders. His research interests include fat cell biology in health and obesity, development of insulin resistance in obesity and diabetes, and cellular mechanisms of diabetic vascular complications. He is also involved in population health and clinical research programmes in diabetes, obesity and lipid disorders. Dr. Lau has published more than 100 scientific papers in peer-reviewed medical journals, periodicals and books.

Dr. Lau is President of Obesity Canada and has served as an expert panel member on the WHO-International Obesity Task Force. He was Chair of the evidence-based Obesity Canada Clinical Practice Guidelines (CPG) Steering Committee and Expert Panel, and lead author of the 2007 CPG publication in the Can. Med. Assoc. Journal. Dr. Lau was a member of the 1998, 2003 and 2008 Canadian Diabetes Association Clinical Practice Guidelines Expert Panel, as well as the expert panel of the 2009 Canadian Cardiovascular Society Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.

In 2004, Dr. Lau was honored as the top 20 notable Calgarians, and top 50 Albertans for his exemplary contributions to improve the health of Albertans.

SAID - As part of his role and function and as expert resource, Dr. Lau may receive payment or financial support and reimbursement for conference costs and may receive grants funding from the regulated NHP industry, and he may provide formal advice or opinion on a matter of relevance to the NHP-PAC and may make public statements on issues of relevance to the NHP-PAC mandate. Dr. Lau is the President of Obesity Canada, the Canadian Diabetes Association and the Heart and Stroke Foundation of Canada, national association that may have an interest in the mandate of the NHP-PAC.

Ms. Krista Rutherford
Regulatory Affairs Coordinator
Canadian Health Food Association

Dr. Simon Wood
(Ph.D., FRSC (UK), C.Chem, C.Sci) is a seasoned manager with business and management experience gained internationally in a cross section of industries and is experienced in: Clinical Trial General Management, Intellectual property and regulations, Product development, Devising, developing and managing multi-million dollar revenue projects and budgets, Project evaluation and International business development. He is currently working on 6 clinical studies in three countries, half a dozen new applications for natural products, regulations for natural products and three new patents for the Factors Group of Nutritional Products. He is also an Adjunct Professor at the University of British Columbia's Food, Nutrition and Health Department.

For the past 13 years, the majority of his time has been in the Natural Products industry, operating from Victoria, BC, Canada. Some of the areas worked on are: Clinical Trials in major countries - GRAS, EU, TGA and NHPD approval and work in Canada, USA, EU, Australia, Japan, Korea, Chile, Argentina and South Africa; structural elucidation of products; and, developing multimillion dollar accounts with companies in the USA and EU. Contract manufacturing, New product development, Medical device invention and development. Prior to this, he was President and CEO of University of Saskatchewan Technologies Inc, the University's technology transfer comp. Before this he worked reorganising a chemical company in Saskatchewan.

Before moving to Canada, Dr. Wood held progressively more senior management positions with Johnson Matthey PLC. These positions included, manufacturing, project management, sales, marketing and restructuring business units. Business was conducted around the world with travel to all global regions. Just before emigrating, Simon was responsible for an operation with a value of over 200 million dollars. In the 1980's in South Africa, he gained valuable skill sets in sales and marketing, human resources, project evaluation and research. This included a 3 year term position as a university lecturer at a Medical University. During this time, these on the job skills were complimented by management training courses (both in house and in a 1 year programme on strategic marketing at the University of the Witwatersrand).

Dr. Wood graduated from the University of Salford in England with a first class honours degree (BSc Honours) in industrial chemistry and engineering in 1978 and an earned PhD with Glaxo Research in Pharmaceutical Organic Chemistry in 1982. Both degrees were obtained in co-operative programmes. Two years work experience at 4 companies was gain during these degrees. He also earned a diploma in strategic marketing from the business school of the University of the Witwatersrand in South Africa. Simon is a Fellow of the Royal Chemical Society (FRSC), a Chartered Chemist (CChem) and Chartered Scientist (C.Sci) and is married to Clare, a medical specialist with one son in university. He currently has 15 publications in professional journals with a further 6 submitted for publication. For relaxation, Dr. Wood enjoys his time with his family, golf, travel, and cooking.

SAID - Dr. Wood acts as a consultant for Factors Group of Nutritional Products, a regulated industry stakeholder. As part of his role and function as consultant, Dr. Wood may receive payment, financial support or other funding from the regulated industry.

Mr. Robert Zielinski
Acting Director, Scientific Affairs
GlaxoSmithKline Consumer Healthcare

Health Products and Food Branch (HPFB) Advisory Body Member Affiliations and Interests Declaration

Each HPFB advisory body member is responsible for the declaration of his or her interests, and the interests of their spouse/partner and/or dependent child. The Affiliations and Interest Declaration forms are updated annually or when there is a change in a member's status. The summary of declaration is made available on the Health Canada website in accordance with the HPFB commitment to be transparent about the membership of its advisory bodies.

Prior to every meeting, the chair will review members' declarations in light of the various items on the agenda. Based on this review, a decision is taken, if necessary, to reduce or refuse a member's participation for all or parts of the meeting agenda, and communicated to the member. Upon receipt of the meeting agenda, members are also expected to review their own affiliations and interests against agenda items and advise the chair and secretariat if they see a potential cause for concern regarding the integrity and objectivity of their participation.

In accordance with the HPFB Review of Regulated Products: Policy on Public Input and Guidance on Advisory Bodies, a person with a direct financial interest in the outcome of a review of a regulated product, or class of products, may be a member of an advisory body whose mandate encompasses matters of policy, management, or program development. However, such a member may not participate in any discussion, formulation of advice, or recommendations by the advisory body to the Branch relating to that review.

HPFB advisory body members provide information on the following affiliations and interests areas:

Direct financial interests

• 1. With the regulated industry of relevance to the NHP-PAC mandate, including current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares, or bonds, with the regulated industry.

Indirect financial interests

• 2. Within the last five years, received from the regulated industry payment for work done or being done, or financial support, of relevance to the NHP-PAC mandate including past employment, contracts, consulting, research support, personal education grants, contributions, fellowships, sponsorships, teaching honoraria, other than present employer.
• 3. Within the last five years, materials, discounted products, gifts or other benefits, or attendance at meetings where all or part of the travel and accommodation costs provided by the regulated industry, other than from present employer, over $1,000.
• 4. Within the last three years, received grants or other funding from the regulated industry to any of the organizations where you are currently employed or participate in internal decision-making, for example as board member, or executive or non-executive director.

Intellectual interests

• 5. Within the last five years, provided any formal advice or opinion to the regulated industry, a government or non-government organization on a matter of relevance to the NHP-PAC mandate, including expert testimony or acting as witness (full or part time), participation on an advisory body, etc.
• 6. Within the last five years, made a public statement, including speeches, lobbying, etc., or publicly stated a point of view, including scientific papers, articles, journals, or other publications or on Web sites, on issues of relevance to the NHP-PAC mandate.
• 7. Currently have any professional or volunteer affiliations such as membership of professional/scientific societies, trade associations, lobbying, public interest or advocacy group, etc., who may have an interest in the mandate and work of the NHP-PAC.

Other

• 8. Any other affiliations and interests or potential circumstances that might give a well informed member of the public reasonable grounds for concern regarding the integrity and objectivity of your participation in the NHP-PAC.